Select license type

Please Select Linenece Type

Key Benefits

  • Consult directly with our domain leaders and get expert advice regarding the upcoming market.
  • Get the latest market insights and forecasts backed up by powerful research and statistical analysis
  • Customize the report as per your requirements and area of focus to avail great benefits for your business.

our clients
tiltle-brk

client-logo
client-logo2
client-logo3
client-logo4
client-logo
client-logo
client-logo
client-logo

"The quality of representation was outstanding. I never thought that understanding a complex market can be that much easy"

Adam Smith, Associate Director, Bain Capital

"More than just selling a report, the team was more focused towards the understanding of my requirements. Regular updation was the best part."

Koh Vivian, Product Development Manager, Swiss Bio Pharma

"Hats off to expert analysis, the team was very supporting and thanks for not charging me on additional data."

Erin Green, Director, Green Energy Consulting

" I really want to thank Goldstein Research for their efforts to make my project successful. F2F discussion with the market experts was excellent. Keep up the good work guyz "

Jorge Foyo, , Analyst, BCG
Market Research Report

Imaging Biomarker Market By Imaging Technology( CT, PET, MRI, US, SPECT), By Product Type(Hormones, Enzymes, Antibodies, Gene products), By Therapeutic Areas(Oncology, Cardiology, Immunology, Neurology), By Application(Drug Discovery, Disease Diagnosis, Genetic Studies, Molecular Diagnostics, Bioinformatics), By End-User

Published On : 2018-10-16 Report Page : 310 Category: Healthcare

Imaging Biomarkers Market in the Global Industry Landscape

Imaging biomarker market is swiftly growing with the advancement in technologies and research & development in the field of disease diagnosis and drug discovery. Biomarker indicates the risk of any disease in any part of the body and with the use of imaging technology biomarkers reveals the exact site of the possible disease even in their early stage. The global fight against cancer management is leading the application of imaging biomarker. Increasing number of hospitals, toxicity profiling cases and targeted drug discovery are driving the growth of the market.

Further, imaging biomarker has led to a trend of ‘precision medicine’ wherein the tailored treatment is available to the individual patient. Such as in oncology, multiple layers of patient data is considered while treating a patient which includes family history, demographics, tissue, and blood markers. The information is used for disease screening, prognosis, differential diagnosis, and prediction of treatment in terms of response or recurrence. Furthermore, the use of imaging biomarkers in clinical trials has led to the development of new drugs and operational efficiencies, that hasn’t been fully realized yet. Also, the reading, homogenizing and easing radiological conclusion facilitates the clinical trials conducted by the companies.

Our Global Imaging Biomarkers Market can be segmented on the following basis:

By Imaging Technology

  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound (US)
  • Single Photon Emission Computed Tomography (SPECT)

By Product Type

  • Hormones
  • Enzymes
  • Antibodies
  • Gene products

By Therapeutic Areas

  • Oncology
  • Cardiology
  • Immunology
  • Neurology
  • Others (Hematology, Biochemistry, etc.)

By Application

  • Drug Discovery and Development
  • Disease Diagnosis
  • Genetic Studies
  • Molecular Diagnostics
  • Bioinformatics
  • Others (Forensic Application, etc.)

By End-User

  • Pharmaceutical Companies
  • Hospitals
  • Research Labs and Institutes
  • Contract Research Organizations (CROs)

By Geography

  • North America (U.S. & Canada)  Imaging Biomarkers Market {Market Share (%), Market Size (USD Billion)}
  • Latin America (Brazil, Mexico, Argentina & Rest Of Latin America) Imaging Biomarkers Market {Market Share (%), Market Size (USD Billion)}
  • Europe (The U.K., Germany, France, Italy, Hungary, Spain, Poland, Sweden & Roe)  Imaging Biomarkers Market {Market Share (%), Market Size (USD Billion)}
  • Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest Of Asia)  Imaging Biomarkers Market {Market Share (%), Market Size (USD Billion)}
  • Middle East & Africa (GCC, South Africa, North Africa, Romea) Imaging Biomarkers Market {Market Share (%), Market Size (USD Billion)}

Global Imaging Biomarkers Market Outlook comprises of the following data:

  • Global Imaging Biomarkers Market by Value, Volume and Average Selling Price, 2017-2025
  • Coverage Numbers and Type of Imaging Biomarkers in Clinical Use, 2016-2017
  • Number of People Diagnosed with Diseases at Primary Stage, 2017-2025
  • New Entrants in the Global Imaging Market, 2016-2017
  • Patent Application and Grant in Imaging Biomarker (USD), 2017-2025
  • Global Imaging Biomarkers Market by Distributor Analysis (USD), 2016-2017

In 2016 on the basis of imaging technology, MRI segmented accounted for the largest market share of the total imaging biomarker market. The MRI technology uses a magnetic field and is also safer to use as compared to other technologies, thus leading to higher attraction from the service providers such as hospitals. Further, CT technology is able take more images in a short period of time. Therefore, in the near future CT technology is expected to be touching heights in the overall market.

Regardless of the obvious value of imaging, imaging biomarkers undertrials are facing few challenges, such as the lack of standardization throughout the multivendor platforms, the complexity of imaging techniques, and lack of improved trial design and operational support.

In November 2017, Bioclinica, the global leading provider of Medical Imaging, eHealth, and patient-centric solutions had acquired MDDX Research & Informatics, having one of the most advanced cloud research image management and submission technologies to effectively, accurately and reliably manage the clinical trials in terms of critical medical imaging.

Expert Analysis: Imaging biomarkers are successfully in use over a past decade. Large number of imaging biomarkers are used for the purpose of drug discovery and eliminating diseases from the root cause. Yet imaging biomarkers market has to unbind the numerous possibilities based on the stage of drug discovery with the support of advancing technologies.

For a full detailed overview, send us the sample request.

Key questions answered in this Global Imaging Biomarker Market Report

  • What is the total market size by 2025 and what would be the expected growth rate of the market?
  • What is the total revenue per segment and region in 2015-16 and what would be the expected revenue per segment and region over the forecast period?
  • What are the key market trends?
  • What are the factors which are driving this market?
  • What are the major barriers to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities for the existing and entry-level players?
  • What are the recent developments and business strategy of the key players?

Reasons to buy this market study

  • Facilitate decision-making based on strong historic and forecast data for global Imaging Biomarker Market
  • Develop strategies based on the latest regulatory framework
  • Position yourself to gain the maximum advantage of the global Imaging Biomarker market’s growth potential
  • Identify key partners and business development avenues across the globe
  • Respond to your competitors’ business structure, strategy and prospects

Global Imaging Biomarkers Market- Table of Contents

1. Research Methodology
1.1. Secondary Research
1.2. Primary Research
1.3. Data Analyzing & Market Size Estimation 
1.4. Research Design
1.5. Bottom-Up & Top-Down Approach
 
2. Market Environment
2.1. Global Economic Overview
2.2. Macroeconomic Outlook
2.3. Global Healthcare Industry Overview
2.4. Global Pharmaceuticals Industry Outlook
2.5. Global Clinical Research & Medical Diagnostics Outlook
2.6. Global Drug Discovery Technology Outlook
2.7. Global Medical Imaging Market Analysis
2.8. Pipeline Products Analysis
 
3. Industry Structure
3.1. Target Consumer Group Analysis
3.2. Target Markets (By Countries)
3.3. Developed & Emerging Markets
3.4. Government & Private Investments Outlook
3.5. Healthcare Reforms Outlook
3.6. Regulatory & Environmental Framework Analysis
 
4. Executive Summary
4.1. Market Size (USD Million)
4.2. Forecast Analysis (2017-2025)
4.3. Market Share & CAGR (%)
4.4. Regional Share Distribution (%)
 
5. Market Dynamics
5.1. Growth Drivers
5.2. Market Restraints
5.3. Risk Analysis
5.4. Recent Trends & Developments
5.5. Opportunities for Market Players
 
6. Global Imaging Biomarkers Market  Segmentation Analysis, 2017-2025
 
6.1. Global Imaging Biomarkers Market Analysis, By Imaging Technology 
6.1.1. Computed Tomography (CT)
6.1.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.1.1.2. Y-o-Y Growth (%), 2017-2025
6.1.1.3. Market Share (%), 2017-2025
6.1.2. Positron Emission Tomography (PET)
6.1.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.1.2.2. Y-o-Y Growth (%), 2017-2025
6.1.2.3. Market Share (%), 2017-2025
6.1.3. Magnetic Resonance Imaging (MRI)
6.1.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.1.3.2. Y-o-Y Growth (%), 2017-2025
6.1.3.3. Market Share (%), 2017-2025
6.1.4. Ultrasound (US)
6.1.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.1.4.2. Y-o-Y Growth (%), 2017-2025
6.1.4.3. Market Share (%), 2017-2025
6.1.5. Single Photon Emission Computed Tomography (SPECT)
6.1.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.1.5.2. Y-o-Y Growth (%), 2017-2025
6.1.5.3. Market Share (%), 2017-2025
6.1.6. BPS Analysis of Imaging Biomarkers Market By Imaging Technology
6.1.7. Market Attractiveness of Imaging Biomarkers Market By Imaging Technology
 
6.2. Global Imaging Biomarkers Market Analysis, By Product Type
6.2.1. Hormones
6.2.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.2.1.2. Y-o-Y Growth (%), 2017-2025
6.2.1.3. Market Share (%), 2017-2025
6.2.2. Enzymes
6.2.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.2.2.2. Y-o-Y Growth (%), 2017-2025
6.2.2.3. Market Share (%), 2017-2025
6.2.3. Antibodies
6.2.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.2.3.2. Y-o-Y Growth (%), 2017-2025
6.2.3.3. Market Share (%), 2017-2025
6.2.4. Gene products
6.2.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.2.4.2. Y-o-Y Growth (%), 2017-2025
6.2.4.3. Market Share (%), 2017-2025
6.2.5. BPS Analysis of Imaging Biomarkers Market By Product Type
6.2.6. Market Attractiveness of Imaging Biomarkers Market By Product Type
 
6.3. Global Imaging Biomarkers Market Analysis, By Therapeutic Areas 
6.3.1. Oncology
6.3.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.3.1.2. Y-o-Y Growth (%), 2017-2025
6.3.1.3. Market Share (%), 2017-2025
6.3.2. Cardiology
6.3.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.3.2.2. Y-o-Y Growth (%), 2017-2025
6.3.2.3. Market Share (%), 2017-2025
6.3.3. Immunology
6.3.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.3.3.2. Y-o-Y Growth (%), 2017-2025
6.3.3.3. Market Share (%), 2017-2025
6.3.4. Neurology
6.3.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.3.4.2. Y-o-Y Growth (%), 2017-2025
6.3.4.3. Market Share (%), 2017-2025
6.3.5. Others (Hematology, Biochemistry, etc.)
6.3.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.3.5.2. Y-o-Y Growth (%), 2017-2025
6.3.5.3. Market Share (%), 2017-2025
6.3.6. BPS Analysis of Imaging Biomarkers Market By Therapeutic Areas
6.3.7. Market Attractiveness of Imaging Biomarkers Market By Therapeutic Areas
 
6.4. Global Imaging Biomarkers Market Analysis, By Application
6.4.1. Drug Discovery and Development
6.4.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.4.1.2. Y-o-Y Growth (%), 2017-2025
6.4.1.3. Market Share (%), 2017-2025
6.4.2. Disease Diagnosis
6.4.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.4.2.2. Y-o-Y Growth (%), 2017-2025
6.4.2.3. Market Share (%), 2017-2025
6.4.3. Genetic Studies
6.4.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.4.3.2. Y-o-Y Growth (%), 2017-2025
6.4.3.3. Market Share (%), 2017-2025
6.4.4. Molecular Diagnostics
6.4.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.4.4.2. Y-o-Y Growth (%), 2017-2025
6.4.4.3. Market Share (%), 2017-2025
6.4.5. Bioinformatics
6.4.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.4.5.2. Y-o-Y Growth (%), 2017-2025
6.4.5.3. Market Share (%), 2017-2025
6.4.6. Others (Forensic Application, etc.)
6.4.6.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.4.6.2. Y-o-Y Growth (%), 2017-2025
6.4.6.3. Market Share (%), 2017-2025
6.4.7. BPS Analysis of Imaging Biomarkers Market By Application
6.4.8. Market Attractiveness of Imaging Biomarkers Market By Application
 
6.5. Global Imaging Biomarkers Market Analysis, By End User
6.5.1. Pharmaceutical Companies
6.5.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.5.1.2. Y-o-Y Growth (%), 2017-2025
6.5.1.3. Market Share (%), 2017-2025
6.5.2. Hospitals
6.5.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.5.2.2. Y-o-Y Growth (%), 2017-2025
6.5.2.3. Market Share (%), 2017-2025
6.5.3. Research Labs and Institutes
6.5.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.5.3.2. Y-o-Y Growth (%), 2017-2025
6.5.3.3. Market Share (%), 2017-2025
6.5.4. Contract Research Organizations (CROs)
6.5.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.5.4.2. Y-o-Y Growth (%), 2017-2025
6.5.4.3. Market Share (%), 2017-2025
6.5.5. BPS Analysis of Imaging Biomarkers Market By End User
6.5.6. Market Attractiveness of Imaging Biomarkers Market By End User
 
6.6. Global Imaging Biomarkers Market Analysis, By Region, 2017-2025
 
6.6.1. North America Imaging Biomarkers Market Outlook, 2017-2025
 
6.6.1.1. North America Imaging Biomarkers Market Analysis, By Country
6.6.1.1.1. U.S. Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.1.1.2.  Canada Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.1.1.3. BPS Analysis of Imaging Biomarkers Market By Country
6.6.1.1.4. Market Attractiveness of Imaging Biomarkers Market By Country
 
6.6.1.2. North America Imaging Biomarkers Market Analysis, By Imaging Technology 
6.6.1.2.1. Computed Tomography (CT)
6.6.1.2.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.2.1.2. Y-o-Y Growth (%), 2017-2025
6.6.1.2.1.3. Market Share (%), 2017-2025
6.6.1.2.2. Positron Emission Tomography (PET)
6.6.1.2.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.2.2.2. Y-o-Y Growth (%), 2017-2025
6.6.1.2.2.3. Market Share (%), 2017-2025
6.6.1.2.3. Magnetic Resonance Imaging (MRI)
6.6.1.2.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.2.3.2. Y-o-Y Growth (%), 2017-2025
6.6.1.2.3.3. Market Share (%), 2017-2025
6.6.1.2.4. Ultrasound (US)
6.6.1.2.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.2.4.2. Y-o-Y Growth (%), 2017-2025
6.6.1.2.4.3. Market Share (%), 2017-2025
6.6.1.2.5. Single Photon Emission Computed Tomography (SPECT)
6.6.1.2.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.2.5.2. Y-o-Y Growth (%), 2017-2025
6.6.1.2.5.3. Market Share (%), 2017-2025
6.6.1.2.6. BPS Analysis of Imaging Biomarkers Market By Imaging Technology
6.6.1.2.7. Market Attractiveness of Imaging Biomarkers Market By Imaging Technology
 
6.6.1.3. North America Imaging Biomarkers Market Analysis, By Product Type
6.6.1.3.1. Hormones
6.6.1.3.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.3.1.2. Y-o-Y Growth (%), 2017-2025
6.6.1.3.1.3. Market Share (%), 2017-2025
6.6.1.3.2. Enzymes
6.6.1.3.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.3.2.2. Y-o-Y Growth (%), 2017-2025
6.6.1.3.2.3. Market Share (%), 2017-2025
6.6.1.3.3. Antibodies
6.6.1.3.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.3.3.2. Y-o-Y Growth (%), 2017-2025
6.6.1.3.3.3. Market Share (%), 2017-2025
6.6.1.3.4. Gene products
6.6.1.3.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.3.4.2. Y-o-Y Growth (%), 2017-2025
6.6.1.3.4.3. Market Share (%), 2017-2025
6.6.1.3.5. BPS Analysis of Imaging Biomarkers Market By Product Type
6.6.1.3.6. Market Attractiveness of Imaging Biomarkers Market By Product Type
 
6.6.1.4. North America Imaging Biomarkers Market Analysis, By Therapeutic Areas 
6.6.1.4.1. Oncology
6.6.1.4.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.4.1.2. Y-o-Y Growth (%), 2017-2025
6.6.1.4.1.3. Market Share (%), 2017-2025
6.6.1.4.2. Cardiology
6.6.1.4.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.4.2.2. Y-o-Y Growth (%), 2017-2025
6.6.1.4.2.3. Market Share (%), 2017-2025
6.6.1.4.3. Immunology
6.6.1.4.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.4.3.2. Y-o-Y Growth (%), 2017-2025
6.6.1.4.3.3. Market Share (%), 2017-2025
6.6.1.4.4. Neurology
6.6.1.4.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.4.4.2. Y-o-Y Growth (%), 2017-2025
6.6.1.4.4.3. Market Share (%), 2017-2025
6.6.1.4.5. Others (Hematology, Biochemistry, etc.)
6.6.1.4.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.4.5.2. Y-o-Y Growth (%), 2017-2025
6.6.1.4.5.3. Market Share (%), 2017-2025
6.6.1.4.6. BPS Analysis of Imaging Biomarkers Market By Therapeutic Areas
6.6.1.4.7. Market Attractiveness of Imaging Biomarkers Market By Therapeutic Areas
 
6.6.1.5. North America Imaging Biomarkers Market Analysis, By Application
6.6.1.5.1. Drug Discovery and Development
6.6.1.5.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.5.1.2. Y-o-Y Growth (%), 2017-2025
6.6.1.5.1.3. Market Share (%), 2017-2025
6.6.1.5.2. Disease Diagnosis
6.6.1.5.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.5.2.2. Y-o-Y Growth (%), 2017-2025
6.6.1.5.2.3. Market Share (%), 2017-2025
6.6.1.5.3. Genetic Studies
6.6.1.5.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.5.3.2. Y-o-Y Growth (%), 2017-2025
6.6.1.5.3.3. Market Share (%), 2017-2025
6.6.1.5.4. Molecular Diagnostics
6.6.1.5.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.5.4.2. Y-o-Y Growth (%), 2017-2025
6.6.1.5.4.3. Market Share (%), 2017-2025
6.6.1.5.5. Bioinformatics
6.6.1.5.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.5.5.2. Y-o-Y Growth (%), 2017-2025
6.6.1.5.5.3. Market Share (%), 2017-2025
6.6.1.5.6. Others (Forensic Application, etc.)
6.6.1.5.6.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.5.6.2. Y-o-Y Growth (%), 2017-2025
6.6.1.5.6.3. Market Share (%), 2017-2025
6.6.1.5.7. BPS Analysis of Imaging Biomarkers Market By Application
6.6.1.5.8. Market Attractiveness of Imaging Biomarkers Market By Application
 
6.6.1.6. North America Imaging Biomarkers Market Analysis, By End User
6.6.1.6.1. Pharmaceutical Companies
6.6.1.6.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.6.1.2. Y-o-Y Growth (%), 2017-2025
6.6.1.6.1.3. Market Share (%), 2017-2025
6.6.1.6.2. Hospitals
6.6.1.6.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.6.2.2. Y-o-Y Growth (%), 2017-2025
6.6.1.6.2.3. Market Share (%), 2017-2025
6.6.1.6.3. Research Labs and Institutes
6.6.1.6.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.6.3.2. Y-o-Y Growth (%), 2017-2025
6.6.1.6.3.3. Market Share (%), 2017-2025
6.6.1.6.4. Contract Research Organizations (CROs)
6.6.1.6.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.1.6.4.2. Y-o-Y Growth (%), 2017-2025
6.6.1.6.4.3. Market Share (%), 2017-2025
6.6.1.6.5. BPS Analysis of Imaging Biomarkers Market By End User
6.6.1.6.6. Market Attractiveness of Imaging Biomarkers Market By End User
 
6.6.2. Europe Imaging Biomarkers Market Outlook, 2017-2025
 
6.6.2.1. Europe Imaging Biomarkers Market Analysis, By Country
6.6.2.1.1. UK Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.2.1.2.  Germany Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.2.1.3.  France Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.2.1.4.  Italy Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.2.1.5.  Spain Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.2.1.6.  BENELUX Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.2.1.7.  Russia Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.2.1.8.  Sweden Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.2.1.9. Rest of Europe Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.2.1.10. BPS Analysis of Imaging Biomarkers Market By Country
6.6.2.1.11. Market Attractiveness of Imaging Biomarkers Market By Country
 
6.6.2.2. Europe Imaging Biomarkers Market Analysis, By Imaging Technology 
6.6.2.2.1. Computed Tomography (CT)
6.6.2.2.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.2.1.2. Y-o-Y Growth (%), 2017-2025
6.6.2.2.1.3. Market Share (%), 2017-2025
6.6.2.2.2. Positron Emission Tomography (PET)
6.6.2.2.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.2.2.2. Y-o-Y Growth (%), 2017-2025
6.6.2.2.2.3. Market Share (%), 2017-2025
6.6.2.2.3. Magnetic Resonance Imaging (MRI)
6.6.2.2.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.2.3.2. Y-o-Y Growth (%), 2017-2025
6.6.2.2.3.3. Market Share (%), 2017-2025
6.6.2.2.4. Ultrasound (US)
6.6.2.2.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.2.4.2. Y-o-Y Growth (%), 2017-2025
6.6.2.2.4.3. Market Share (%), 2017-2025
6.6.2.2.5. Single Photon Emission Computed Tomography (SPECT)
6.6.2.2.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.2.5.2. Y-o-Y Growth (%), 2017-2025
6.6.2.2.5.3. Market Share (%), 2017-2025
6.6.2.2.6. BPS Analysis of Imaging Biomarkers Market By Imaging Technology
6.6.2.2.7. Market Attractiveness of Imaging Biomarkers Market By Imaging Technology
 
6.6.2.3. Europe Imaging Biomarkers Market Analysis, By Product Type
6.6.2.3.1. Hormones
6.6.2.3.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.3.1.2. Y-o-Y Growth (%), 2017-2025
6.6.2.3.1.3. Market Share (%), 2017-2025
6.6.2.3.2. Enzymes
6.6.2.3.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.3.2.2. Y-o-Y Growth (%), 2017-2025
6.6.2.3.2.3. Market Share (%), 2017-2025
6.6.2.3.3. Antibodies
6.6.2.3.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.3.3.2. Y-o-Y Growth (%), 2017-2025
6.6.2.3.3.3. Market Share (%), 2017-2025
6.6.2.3.4. Gene products
6.6.2.3.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.3.4.2. Y-o-Y Growth (%), 2017-2025
6.6.2.3.4.3. Market Share (%), 2017-2025
6.6.2.3.5. BPS Analysis of Imaging Biomarkers Market By Product Type
6.6.2.3.6. Market Attractiveness of Imaging Biomarkers Market By Product Type
 
6.6.2.4. Europe Imaging Biomarkers Market Analysis, By Therapeutic Areas 
6.6.2.4.1. Oncology
6.6.2.4.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.4.1.2. Y-o-Y Growth (%), 2017-2025
6.6.2.4.1.3. Market Share (%), 2017-2025
6.6.2.4.2. Cardiology
6.6.2.4.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.4.2.2. Y-o-Y Growth (%), 2017-2025
6.6.2.4.2.3. Market Share (%), 2017-2025
6.6.2.4.3. Immunology
6.6.2.4.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.4.3.2. Y-o-Y Growth (%), 2017-2025
6.6.2.4.3.3. Market Share (%), 2017-2025
6.6.2.4.4. Neurology
6.6.2.4.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.4.4.2. Y-o-Y Growth (%), 2017-2025
6.6.2.4.4.3. Market Share (%), 2017-2025
6.6.2.4.5. Others (Hematology, Biochemistry, etc.)
6.6.2.4.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.4.5.2. Y-o-Y Growth (%), 2017-2025
6.6.2.4.5.3. Market Share (%), 2017-2025
6.6.2.4.6. BPS Analysis of Imaging Biomarkers Market By Therapeutic Areas
6.6.2.4.7. Market Attractiveness of Imaging Biomarkers Market By Therapeutic Areas
 
6.6.2.5. Europe Imaging Biomarkers Market Analysis, By Application
6.6.2.5.1. Drug Discovery and Development
6.6.2.5.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.5.1.2. Y-o-Y Growth (%), 2017-2025
6.6.2.5.1.3. Market Share (%), 2017-2025
6.6.2.5.2. Disease Diagnosis
6.6.2.5.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.5.2.2. Y-o-Y Growth (%), 2017-2025
6.6.2.5.2.3. Market Share (%), 2017-2025
6.6.2.5.3. Genetic Studies
6.6.2.5.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.5.3.2. Y-o-Y Growth (%), 2017-2025
6.6.2.5.3.3. Market Share (%), 2017-2025
6.6.2.5.4. Molecular Diagnostics
6.6.2.5.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.5.4.2. Y-o-Y Growth (%), 2017-2025
6.6.2.5.4.3. Market Share (%), 2017-2025
6.6.2.5.5. Bioinformatics
6.6.2.5.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.5.5.2. Y-o-Y Growth (%), 2017-2025
6.6.2.5.5.3. Market Share (%), 2017-2025
6.6.2.5.6. Others (Forensic Application, etc.)
6.6.2.5.6.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.5.6.2. Y-o-Y Growth (%), 2017-2025
6.6.2.5.6.3. Market Share (%), 2017-2025
6.6.2.5.7. BPS Analysis of Imaging Biomarkers Market By Application
6.6.2.5.8. Market Attractiveness of Imaging Biomarkers Market By Application
 
6.6.2.6. Europe Imaging Biomarkers Market Analysis, By End User
6.6.2.6.1. Pharmaceutical Companies
6.6.2.6.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.6.1.2. Y-o-Y Growth (%), 2017-2025
6.6.2.6.1.3. Market Share (%), 2017-2025
6.6.2.6.2. Hospitals
6.6.2.6.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.6.2.2. Y-o-Y Growth (%), 2017-2025
6.6.2.6.2.3. Market Share (%), 2017-2025
6.6.2.6.3. Research Labs and Institutes
6.6.2.6.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.6.3.2. Y-o-Y Growth (%), 2017-2025
6.6.2.6.3.3. Market Share (%), 2017-2025
6.6.2.6.4. Contract Research Organizations (CROs)
6.6.2.6.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.2.6.4.2. Y-o-Y Growth (%), 2017-2025
6.6.2.6.4.3. Market Share (%), 2017-2025
6.6.2.6.5. BPS Analysis of Imaging Biomarkers Market By End User
6.6.2.6.6. Market Attractiveness of Imaging Biomarkers Market By End User
 
6.6.3. Asia Pacific Imaging Biomarkers Market Outlook, 2017-2025
 
6.6.3.1. Asia Pacific Imaging Biomarkers Market Analysis, By Country
6.6.3.1.1. China Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.3.1.2.  Japan Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.3.1.3.  India Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.3.1.4.  Singapore Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.3.1.5.  Malaysia Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.3.1.6.  Thailand Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.3.1.7. Australia Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.3.1.8.  New Zealand Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.3.1.9.  Rest of APAC Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.3.1.10. BPS Analysis of Imaging Biomarkers Market By Country
6.6.3.1.11. Market Attractiveness of Imaging Biomarkers Market By Country
 
6.6.3.2. Asia Pacific Imaging Biomarkers Market Analysis, By Imaging Technology 
6.6.3.2.1. Computed Tomography (CT)
6.6.3.2.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.2.1.2. Y-o-Y Growth (%), 2017-2025
6.6.3.2.1.3. Market Share (%), 2017-2025
6.6.3.2.2. Positron Emission Tomography (PET)
6.6.3.2.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.2.2.2. Y-o-Y Growth (%), 2017-2025
6.6.3.2.2.3. Market Share (%), 2017-2025
6.6.3.2.3. Magnetic Resonance Imaging (MRI)
6.6.3.2.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.2.3.2. Y-o-Y Growth (%), 2017-2025
6.6.3.2.3.3. Market Share (%), 2017-2025
6.6.3.2.4. Ultrasound (US)
6.6.3.2.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.2.4.2. Y-o-Y Growth (%), 2017-2025
6.6.3.2.4.3. Market Share (%), 2017-2025
6.6.3.2.5. Single Photon Emission Computed Tomography (SPECT)
6.6.3.2.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.2.5.2. Y-o-Y Growth (%), 2017-2025
6.6.3.2.5.3. Market Share (%), 2017-2025
6.6.3.2.6. BPS Analysis of Imaging Biomarkers Market By Imaging Technology
6.6.3.2.7. Market Attractiveness of Imaging Biomarkers Market By Imaging Technology
 
6.6.3.3. Asia Pacific Imaging Biomarkers Market Analysis, By Product Type
6.6.3.3.1. Hormones
6.6.3.3.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.3.1.2. Y-o-Y Growth (%), 2017-2025
6.6.3.3.1.3. Market Share (%), 2017-2025
6.6.3.3.2. Enzymes
6.6.3.3.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.3.2.2. Y-o-Y Growth (%), 2017-2025
6.6.3.3.2.3. Market Share (%), 2017-2025
6.6.3.3.3. Antibodies
6.6.3.3.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.3.3.2. Y-o-Y Growth (%), 2017-2025
6.6.3.3.3.3. Market Share (%), 2017-2025
6.6.3.3.4. Gene products
6.6.3.3.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.3.4.2. Y-o-Y Growth (%), 2017-2025
6.6.3.3.4.3. Market Share (%), 2017-2025
6.6.3.3.5. BPS Analysis of Imaging Biomarkers Market By Product Type
6.6.3.3.6. Market Attractiveness of Imaging Biomarkers Market By Product Type
 
6.6.3.4. Asia Pacific Imaging Biomarkers Market Analysis, By Therapeutic Areas 
6.6.3.4.1. Oncology
6.6.3.4.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.4.1.2. Y-o-Y Growth (%), 2017-2025
6.6.3.4.1.3. Market Share (%), 2017-2025
6.6.3.4.2. Cardiology
6.6.3.4.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.4.2.2. Y-o-Y Growth (%), 2017-2025
6.6.3.4.2.3. Market Share (%), 2017-2025
6.6.3.4.3. Immunology
6.6.3.4.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.4.3.2. Y-o-Y Growth (%), 2017-2025
6.6.3.4.3.3. Market Share (%), 2017-2025
6.6.3.4.4. Neurology
6.6.3.4.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.4.4.2. Y-o-Y Growth (%), 2017-2025
6.6.3.4.4.3. Market Share (%), 2017-2025
6.6.3.4.5. Others (Hematology, Biochemistry, etc.)
6.6.3.4.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.4.5.2. Y-o-Y Growth (%), 2017-2025
6.6.3.4.5.3. Market Share (%), 2017-2025
6.6.3.4.6. BPS Analysis of Imaging Biomarkers Market By Therapeutic Areas
6.6.3.4.7. Market Attractiveness of Imaging Biomarkers Market By Therapeutic Areas
 
6.6.3.5. Asia Pacific Imaging Biomarkers Market Analysis, By Application
6.6.3.5.1. Drug Discovery and Development
6.6.3.5.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.5.1.2. Y-o-Y Growth (%), 2017-2025
6.6.3.5.1.3. Market Share (%), 2017-2025
6.6.3.5.2. Disease Diagnosis
6.6.3.5.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.5.2.2. Y-o-Y Growth (%), 2017-2025
6.6.3.5.2.3. Market Share (%), 2017-2025
6.6.3.5.3. Genetic Studies
6.6.3.5.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.5.3.2. Y-o-Y Growth (%), 2017-2025
6.6.3.5.3.3. Market Share (%), 2017-2025
6.6.3.5.4. Molecular Diagnostics
6.6.3.5.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.5.4.2. Y-o-Y Growth (%), 2017-2025
6.6.3.5.4.3. Market Share (%), 2017-2025
6.6.3.5.5. Bioinformatics
6.6.3.5.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.5.5.2. Y-o-Y Growth (%), 2017-2025
6.6.3.5.5.3. Market Share (%), 2017-2025
6.6.3.5.6. Others (Forensic Application, etc.)
6.6.3.5.6.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.5.6.2. Y-o-Y Growth (%), 2017-2025
6.6.3.5.6.3. Market Share (%), 2017-2025
6.6.3.5.7. BPS Analysis of Imaging Biomarkers Market By Application
6.6.3.5.8. Market Attractiveness of Imaging Biomarkers Market By Application
 
6.6.3.6. Asia Pacific Imaging Biomarkers Market Analysis, By End User
6.6.3.6.1. Pharmaceutical Companies
6.6.3.6.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.6.1.2. Y-o-Y Growth (%), 2017-2025
6.6.3.6.1.3. Market Share (%), 2017-2025
6.6.3.6.2. Hospitals
6.6.3.6.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.6.2.2. Y-o-Y Growth (%), 2017-2025
6.6.3.6.2.3. Market Share (%), 2017-2025
6.6.3.6.3. Research Labs and Institutes
6.6.3.6.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.6.3.2. Y-o-Y Growth (%), 2017-2025
6.6.3.6.3.3. Market Share (%), 2017-2025
6.6.3.6.4. Contract Research Organizations (CROs)
6.6.3.6.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.3.6.4.2. Y-o-Y Growth (%), 2017-2025
6.6.3.6.4.3. Market Share (%), 2017-2025
6.6.3.6.5. BPS Analysis of Imaging Biomarkers Market By End User
6.6.3.6.6. Market Attractiveness of Imaging Biomarkers Market By End User
 
6.6.4. Latin America Imaging Biomarkers Market Outlook, 2017-2025
 
6.6.4.1. Latin America Imaging Biomarkers Market Analysis, By Country
6.6.4.1.1. Brazil Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.4.1.2.  Mexico Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.4.1.3.  Rest of Latin America Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025) 
6.6.4.1.4. BPS Analysis of Imaging Biomarkers Market By Country
6.6.4.1.5. Market Attractiveness of Imaging Biomarkers Market By Country
 
6.6.4.2. Latin America Imaging Biomarkers Market Analysis, By Imaging Technology 
6.6.4.2.1. Computed Tomography (CT)
6.6.4.2.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.2.1.2. Y-o-Y Growth (%), 2017-2025
6.6.4.2.1.3. Market Share (%), 2017-2025
6.6.4.2.2. Positron Emission Tomography (PET)
6.6.4.2.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.2.2.2. Y-o-Y Growth (%), 2017-2025
6.6.4.2.2.3. Market Share (%), 2017-2025
6.6.4.2.3. Magnetic Resonance Imaging (MRI)
6.6.4.2.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.2.3.2. Y-o-Y Growth (%), 2017-2025
6.6.4.2.3.3. Market Share (%), 2017-2025
6.6.4.2.4. Ultrasound (US)
6.6.4.2.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.2.4.2. Y-o-Y Growth (%), 2017-2025
6.6.4.2.4.3. Market Share (%), 2017-2025
6.6.4.2.5. Single Photon Emission Computed Tomography (SPECT)
6.6.4.2.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.2.5.2. Y-o-Y Growth (%), 2017-2025
6.6.4.2.5.3. Market Share (%), 2017-2025
6.6.4.2.6. BPS Analysis of Imaging Biomarkers Market By Imaging Technology
6.6.4.2.7. Market Attractiveness of Imaging Biomarkers Market By Imaging Technology
 
6.6.4.3. Latin America Imaging Biomarkers Market Analysis, By Product Type
6.6.4.3.1. Hormones
6.6.4.3.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.3.1.2. Y-o-Y Growth (%), 2017-2025
6.6.4.3.1.3. Market Share (%), 2017-2025
6.6.4.3.2. Enzymes
6.6.4.3.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.3.2.2. Y-o-Y Growth (%), 2017-2025
6.6.4.3.2.3. Market Share (%), 2017-2025
6.6.4.3.3. Antibodies
6.6.4.3.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.3.3.2. Y-o-Y Growth (%), 2017-2025
6.6.4.3.3.3. Market Share (%), 2017-2025
6.6.4.3.4. Gene products
6.6.4.3.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.3.4.2. Y-o-Y Growth (%), 2017-2025
6.6.4.3.4.3. Market Share (%), 2017-2025
6.6.4.3.5. BPS Analysis of Imaging Biomarkers Market By Product Type
6.6.4.3.6. Market Attractiveness of Imaging Biomarkers Market By Product Type
 
6.6.4.4. Latin America Imaging Biomarkers Market Analysis, By Therapeutic Areas 
6.6.4.4.1. Oncology
6.6.4.4.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.4.1.2. Y-o-Y Growth (%), 2017-2025
6.6.4.4.1.3. Market Share (%), 2017-2025
6.6.4.4.2. Cardiology
6.6.4.4.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.4.2.2. Y-o-Y Growth (%), 2017-2025
6.6.4.4.2.3. Market Share (%), 2017-2025
6.6.4.4.3. Immunology
6.6.4.4.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.4.3.2. Y-o-Y Growth (%), 2017-2025
6.6.4.4.3.3. Market Share (%), 2017-2025
6.6.4.4.4. Neurology
6.6.4.4.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.4.4.2. Y-o-Y Growth (%), 2017-2025
6.6.4.4.4.3. Market Share (%), 2017-2025
6.6.4.4.5. Others (Hematology, Biochemistry, etc.)
6.6.4.4.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.4.5.2. Y-o-Y Growth (%), 2017-2025
6.6.4.4.5.3. Market Share (%), 2017-2025
6.6.4.4.6. BPS Analysis of Imaging Biomarkers Market By Therapeutic Areas
6.6.4.4.7. Market Attractiveness of Imaging Biomarkers Market By Therapeutic Areas
 
6.6.4.5. Latin America Imaging Biomarkers Market Analysis, By Application
6.6.4.5.1. Drug Discovery and Development
6.6.4.5.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.5.1.2. Y-o-Y Growth (%), 2017-2025
6.6.4.5.1.3. Market Share (%), 2017-2025
6.6.4.5.2. Disease Diagnosis
6.6.4.5.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.5.2.2. Y-o-Y Growth (%), 2017-2025
6.6.4.5.2.3. Market Share (%), 2017-2025
6.6.4.5.3. Genetic Studies
6.6.4.5.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.5.3.2. Y-o-Y Growth (%), 2017-2025
6.6.4.5.3.3. Market Share (%), 2017-2025
6.6.4.5.4. Molecular Diagnostics
6.6.4.5.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.5.4.2. Y-o-Y Growth (%), 2017-2025
6.6.4.5.4.3. Market Share (%), 2017-2025
6.6.4.5.5. Bioinformatics
6.6.4.5.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.5.5.2. Y-o-Y Growth (%), 2017-2025
6.6.4.5.5.3. Market Share (%), 2017-2025
6.6.4.5.6. Others (Forensic Application, etc.)
6.6.4.5.6.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.5.6.2. Y-o-Y Growth (%), 2017-2025
6.6.4.5.6.3. Market Share (%), 2017-2025
6.6.4.5.7. BPS Analysis of Imaging Biomarkers Market By Application
6.6.4.5.8. Market Attractiveness of Imaging Biomarkers Market By Application
 
6.6.4.6. Latin America Imaging Biomarkers Market Analysis, By End User
6.6.4.6.1. Pharmaceutical Companies
6.6.4.6.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.6.1.2. Y-o-Y Growth (%), 2017-2025
6.6.4.6.1.3. Market Share (%), 2017-2025
6.6.4.6.2. Hospitals
6.6.4.6.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.6.2.2. Y-o-Y Growth (%), 2017-2025
6.6.4.6.2.3. Market Share (%), 2017-2025
6.6.4.6.3. Research Labs and Institutes
6.6.4.6.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.6.3.2. Y-o-Y Growth (%), 2017-2025
6.6.4.6.3.3. Market Share (%), 2017-2025
6.6.4.6.4. Contract Research Organizations (CROs)
6.6.4.6.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.4.6.4.2. Y-o-Y Growth (%), 2017-2025
6.6.4.6.4.3. Market Share (%), 2017-2025
6.6.4.6.5. BPS Analysis of Imaging Biomarkers Market By End User
6.6.4.6.6. Market Attractiveness of Imaging Biomarkers Market By End User
 
6.6.5. Middle East & Africa Imaging Biomarkers Market Outlook, 2017-2025
 
6.6.5.1. Middle East & Africa Imaging Biomarkers Market Analysis, By Country
6.6.5.1.1. GCC Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.5.1.2.  North Africa Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025)
6.6.5.1.3.  South Africa Imaging Biomarkers Market Outlook (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2017-2025) 
6.6.5.1.4. BPS Analysis of Imaging Biomarkers Market By Country
6.6.5.1.5. Market Attractiveness of Imaging Biomarkers Market By Country
 
6.6.5.2. Middle East & Africa Imaging Biomarkers Market Analysis, By Imaging Technology 
6.6.5.2.1. Computed Tomography (CT)
6.6.5.2.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.2.1.2. Y-o-Y Growth (%), 2017-2025
6.6.5.2.1.3. Market Share (%), 2017-2025
6.6.5.2.2. Positron Emission Tomography (PET)
6.6.5.2.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.2.2.2. Y-o-Y Growth (%), 2017-2025
6.6.5.2.2.3. Market Share (%), 2017-2025
6.6.5.2.3. Magnetic Resonance Imaging (MRI)
6.6.5.2.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.2.3.2. Y-o-Y Growth (%), 2017-2025
6.6.5.2.3.3. Market Share (%), 2017-2025
6.6.5.2.4. Ultrasound (US)
6.6.5.2.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.2.4.2. Y-o-Y Growth (%), 2017-2025
6.6.5.2.4.3. Market Share (%), 2017-2025
6.6.5.2.5. Single Photon Emission Computed Tomography (SPECT)
6.6.5.2.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.2.5.2. Y-o-Y Growth (%), 2017-2025
6.6.5.2.5.3. Market Share (%), 2017-2025
6.6.5.2.6. BPS Analysis of Imaging Biomarkers Market By Imaging Technology
6.6.5.2.7. Market Attractiveness of Imaging Biomarkers Market By Imaging Technology
 
6.6.5.3. Middle East & Africa Imaging Biomarkers Market Analysis, By Product Type
6.6.5.3.1. Hormones
6.6.5.3.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.3.1.2. Y-o-Y Growth (%), 2017-2025
6.6.5.3.1.3. Market Share (%), 2017-2025
6.6.5.3.2. Enzymes
6.6.5.3.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.3.2.2. Y-o-Y Growth (%), 2017-2025
6.6.5.3.2.3. Market Share (%), 2017-2025
6.6.5.3.3. Antibodies
6.6.5.3.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.3.3.2. Y-o-Y Growth (%), 2017-2025
6.6.5.3.3.3. Market Share (%), 2017-2025
6.6.5.3.4. Gene products
6.6.5.3.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.3.4.2. Y-o-Y Growth (%), 2017-2025
6.6.5.3.4.3. Market Share (%), 2017-2025
6.6.5.3.5. BPS Analysis of Imaging Biomarkers Market By Product Type
6.6.5.3.6. Market Attractiveness of Imaging Biomarkers Market By Product Type
 
6.6.5.4. Middle East & Africa Imaging Biomarkers Market Analysis, By Therapeutic Areas 
6.6.5.4.1. Oncology
6.6.5.4.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.4.1.2. Y-o-Y Growth (%), 2017-2025
6.6.5.4.1.3. Market Share (%), 2017-2025
6.6.5.4.2. Cardiology
6.6.5.4.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.4.2.2. Y-o-Y Growth (%), 2017-2025
6.6.5.4.2.3. Market Share (%), 2017-2025
6.6.5.4.3. Immunology
6.6.5.4.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.4.3.2. Y-o-Y Growth (%), 2017-2025
6.6.5.4.3.3. Market Share (%), 2017-2025
6.6.5.4.4. Neurology
6.6.5.4.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.4.4.2. Y-o-Y Growth (%), 2017-2025
6.6.5.4.4.3. Market Share (%), 2017-2025
6.6.5.4.5. Others (Hematology, Biochemistry, etc.)
6.6.5.4.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.4.5.2. Y-o-Y Growth (%), 2017-2025
6.6.5.4.5.3. Market Share (%), 2017-2025
6.6.5.4.6. BPS Analysis of Imaging Biomarkers Market By Therapeutic Areas
6.6.5.4.7. Market Attractiveness of Imaging Biomarkers Market By Therapeutic Areas
 
6.6.5.5. Middle East & Africa Imaging Biomarkers Market Analysis, By Application
6.6.5.5.1. Drug Discovery and Development
6.6.5.5.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.5.1.2. Y-o-Y Growth (%), 2017-2025
6.6.5.5.1.3. Market Share (%), 2017-2025
6.6.5.5.2. Disease Diagnosis
6.6.5.5.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.5.2.2. Y-o-Y Growth (%), 2017-2025
6.6.5.5.2.3. Market Share (%), 2017-2025
6.6.5.5.3. Genetic Studies
6.6.5.5.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.5.3.2. Y-o-Y Growth (%), 2017-2025
6.6.5.5.3.3. Market Share (%), 2017-2025
6.6.5.5.4. Molecular Diagnostics
6.6.5.5.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.5.4.2. Y-o-Y Growth (%), 2017-2025
6.6.5.5.4.3. Market Share (%), 2017-2025
6.6.5.5.5. Bioinformatics
6.6.5.5.5.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.5.5.2. Y-o-Y Growth (%), 2017-2025
6.6.5.5.5.3. Market Share (%), 2017-2025
6.6.5.5.6. Others (Forensic Application, etc.)
6.6.5.5.6.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.5.6.2. Y-o-Y Growth (%), 2017-2025
6.6.5.5.6.3. Market Share (%), 2017-2025
6.6.5.5.7. BPS Analysis of Imaging Biomarkers Market By Application
6.6.5.5.8. Market Attractiveness of Imaging Biomarkers Market By Application
 
6.6.5.6. Middle East & Africa Imaging Biomarkers Market Analysis, By End User
6.6.5.6.1. Pharmaceutical Companies
6.6.5.6.1.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.6.1.2. Y-o-Y Growth (%), 2017-2025
6.6.5.6.1.3. Market Share (%), 2017-2025
6.6.5.6.2. Hospitals
6.6.5.6.2.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.6.2.2. Y-o-Y Growth (%), 2017-2025
6.6.5.6.2.3. Market Share (%), 2017-2025
6.6.5.6.3. Research Labs and Institutes
6.6.5.6.3.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.6.3.2. Y-o-Y Growth (%), 2017-2025
6.6.5.6.3.3. Market Share (%), 2017-2025
6.6.5.6.4. Contract Research Organizations (CROs)
6.6.5.6.4.1. Market Size ($ Billion), CAGR (%), 2017-2025 
6.6.5.6.4.2. Y-o-Y Growth (%), 2017-2025
6.6.5.6.4.3. Market Share (%), 2017-2025
6.6.5.6.5. BPS Analysis of Imaging Biomarkers Market By End User
6.6.5.6.6. Market Attractiveness of Imaging Biomarkers Market By End User
 
7. Competitive Analysis
7.1. Company Profiles of Major Players
7.1.1. Abbott Laboratories
7.1.1.1. Financial Analysis
7.1.1.2. Business Strategy
7.1.1.3. Product Portfolio
7.1.1.4. Global Presence
7.1.2. Roche Diagnostics Ltd. 
7.1.3. Merck Millipore
7.1.4. Qiagen N.V.
7.1.5. Siemens Healthcare GmbH
7.1.6. GE Healthcare
7.1.7. Bio-Rad Laboratories, Inc.
7.1.8. Thermo Fisher Scientific, Inc.
7.1.9. Agilent Technologies, Inc.
7.1.10. Merck & Co., Inc.
7.1.11. Johnson & Johnson
7.1.12. Enzo Biochem, Inc.
7.1.13. Biosims Technologies Sas
7.1.14. Meso Scale Diagnostics, LLC.
7.1.15. Bio-Rad Laboratories, Inc.
 
8. Porter’s Five Force Model
 
9. Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem 
 
10. Expert Analysis
 
11. Concluding Remarks
 

Imaging Biomarker Market By Imaging Technology( CT, PET, MRI, US, SPECT), By Product Type(Hormones, Enzymes, Antibodies, Gene products), By Therapeutic Areas(Oncology, Cardiology, Immunology, Neurology), By Application(Drug Discovery, Disease Diagnosis, Genetic Studies, Molecular Diagnostics, Bioinformatics), By End-User

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

Send Enquiry


Need more information about this report ?


Send Enquiry